MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells

Glioma is the most common malignant tumor of the central nervous system with poor survival. Temozolomide (TMZ) is the first-line chemotherapy drug for initial and recurrent glioma treatment with a relatively good efficacy, which exerts its antitumor effects mainly through cell death induced by DNA d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongqin, Ren, Shuxian, Xu, Yongming, Miao, Wang, Huang, Xintao, Qu, Zhizhao, Li, Jinhu, Liu, Xiaodong, Kong, Pengzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Preclinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287895/
https://www.ncbi.nlm.nih.gov/pubmed/30273182
http://dx.doi.org/10.1097/CAD.0000000000000700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287895/
https://www.ncbi.nlm.nih.gov/pubmed/30273182
http://dx.doi.org/10.1097/CAD.0000000000000700

Ejemplares similares